Astrana Health Narrows FY2026 Sales Guidance from $3.800B-$4.100B to $3.900B-$4.000B vs $3.980B Est
Astrana Health (NASDAQ:ASTH) narrows FY2026 sales outlook from $3.800 billion-$4.100 billion to $3.900 billion-$4.000 billion vs $3.980 billion estimate.
Share
Why It Matters
Astrana Health made its sales prediction range smaller and tighter. This shows the company feels more sure about what's coming, even if the range shifted a bit lower.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.